Financings in Brief: Affymetrix
This article was originally published in The Gray Sheet
Executive Summary
Affymetrix: Completes a $39 mil. private placement to institutional investors in the U.S. and Europe. The Santa Clara, California-based developer of GeneChip systems to "acquire, analyze, manage and use genetic information" says that its founding company Affymax invested $6 mil. in the offering. Affymax, a subsidiary of Glaxo Wellcome, now owns 47% of Affymetrix...